A large-scale study published in the British medical journal BMJ has concluded that “there is no evidence establishing a link between taking paracetamol during pregnancy and the development of autism spectrum disorders in children.”
The study explains that “the currently available data are insufficient to prove any association between fetal exposure to paracetamol in the womb and autism or attention deficit hyperactivity disorder (ADHD) during childhood.”
Scientific circles also emphasize that paracetamol remains the recommended painkiller for pregnant women, unlike aspirin or ibuprofen, which have well-documented risks for the fetus. The World Health Organization has likewise confirmed that there is no conclusive evidence that paracetamol increases the risk of autism in unborn children.
The study, published in BMJ, reinforces this medical consensus by confirming earlier research that sought to provide a comprehensive assessment of current knowledge on the topic.
